Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Dr. Lal Pathlabs has informed that it enclosed the details of proposed schedule of Analyst/Institutional Investor meeting(s) to be held on February 24, 2022.
The above information is a part of company’s filings submitted to BSE.